相关实验视频

Updated: May 6, 2026

A Detailed Protocol for Physiological Parameters Acquisition and Analysis in Neurosurgical Critical Patients

A Detailed Protocol for Physiological Parameters Acquisition and Analysis in Neurosurgical Critical Patients

Published on: October 17, 2017

正常压力脑症中的生物标志物:一篇小小的回顾

Anderson Silva Corin¹, Gabriel Semione², Leonardo B O Brenner³

¹Federal University of Pelotas, Pelotas, RS, Brazil.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

|July 25, 2025

概括

鉴定正常压力脑水症 (NPH) 的生物标志物对于准确诊断至关重要. 本次审查强调了诸如蛋白和β-粉样蛋白等关键生物标志物,这些生物标志物在改善NPH患者管理方面显示出有前途.

科学领域:

神经学神经学
神经科学是一个神经科学.
生物标志物研究生物标志物研究

背景情况:

正常压力脑水 (NPH) 呈现出走路障碍,认知障碍和尿失禁.
由于症状与其他神经退行性疾病重叠,诊断具有挑战性.
准确的诊断对于有效的治疗策略至关重要.

研究的目的:

系统地审查和识别正常压力水脑病 (NPH) 的潜在生物标志物.
解决NPH的诊断差距,提高诊断准确度.
为指导NPH未来的治疗和管理策略.

主要方法:

按照PRISMA指南进行系统的文献搜索.
搜索的数据库包括Embase,PubMed,Scopus,Cochrane和科学网络.
纳入标准集中在英语文章,讨论临床NPH研究中的生物标志物.

主要成果:

对91篇文章的分析确定了几个关键生物标志物.
常见的生物标志物包括β-粉样蛋白,tau蛋白和神经丝轻蛋白.
其他重要的生物标志物包括可溶性粉样蛋白前体蛋白,富含白氨酸的α-2-糖蛋白-1,Glial纤维酸蛋白,Interleukins和单细胞化学吸引蛋白1.

结论:

生物标志物可以通过预测严重程度,并发症和预后,显著提高NPH管理.
已识别的生物标志物显示出改善NPH诊断和监测疾病进展的潜力.
尽管目前的准确性差距很大,但有前途的生物标志物可能很快会改善患者的治疗结果.

关键词:

生物标志物生物标志物大脑脊髓液是如何形成的诊断诊断诊断诊断诊断神经成像是一种神经成像.神经系统疾病神经系统疾病正常压力脑水脑水

更多相关视频

A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury

A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury

Published on: March 26, 2019

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Published on: February 8, 2022

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Cerebral Edema l: Introduction

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...